Stroke prevention in patients with AF has largely been based on the use of anticoagulation with warfarin and recently with direct thrombin inhibitor dabigatran and the selective factor Xa inhibitors apixaban and rivaroxaban. This evidence concerns the gene F10 and Stroke.